Director, formulary operations, Capital Rx, a pharmacy benefits manager and healthcare technology company
I grew up in East Brunswick, New Jersey, and went to Rutgers University for pharmacy school, where I ,received my doctor of pharmacy degree. I learned the value of hard work, dedication and grit from my entrepreneurial parents, who motivated me to continue training through residency and fellowship. I was the first postgraduate year (PGY) 2 corporate health-system pharmacy administration resident and the first executive pharmacy leadership and supply chain management fellow at Ascension/The Resource Group. The exposure and learning from those two years set me up for every opportunity I have had since.
As director of formulary operations and the PGY1 managed care residency program director, I built the formulary operations team from the ground up to serve all lines of business, including commercial, health insurance marketplaces, Medicaid and Medicare, and supported the company’s state-of-the-art claim adjudication platform. I serve in multiple local, regional and national committees and positions, including the US Pharmacopeia healthcare safety and quality
expert committee.
Most of my career has been steadily built upon experiences and opportunities. I found confidence in myself when I created my first pharmacist role as Ascension senior manager of pharmacy deployment following residency and fellowship training. I was able to take all the learning and experiences from pharmacy school and postdoc training and apply it in a professional setting. From leading mergers and hospital acquisitions to operationalizing Accreditation Council for Pharmacy Education-accredited continuing education to supporting over 120 health system clinical and operational initiatives, I came into my own as a healthcare and pharmacy leader and had the support of my mentors and leaders.
As a leader in healthcare, I continue to prioritize staying on top of the always-changing healthcare landscape as well as pipeline medication approvals and changes. Additionally, I prioritize developing future pharmacy leaders by leading Capital Rx’s advanced pharmacy practice experiences program with multiple schools of pharmacy and directing our PGY1 Managed Care
Residency Program.
Much of healthcare is siloed and segmented, which can be confusing to both patients and healthcare teams. If I could change one thing, it would be integration of all health information, through perhaps unified healthcare claims processing, in one place for it to be available to those taking
care of patients.
I recommend that everyone read the various articles KFF Health News publishes. KFF is an independent source for health policy research, polling and journalism, and it does a great job of explaining impactful and complicated health policy issues in a clear and understandable way.
It is always tough to strike the right work-life balance, especially early in one’s career, when you do not want to give up an exciting learning or growth opportunity. I strive every day to utilize my personal and work calendars to prioritize items and due dates, delegate when possible and disconnect completely to be fully present at home with family when away from the computer.
I wish I could have dinner with myself when I was around 23 years old to help that version of myself see the many possibilities the future holds and how to be excited about them. Otherwise, I would have dinner with Warren Buffett because he explains things in graspable ways that everyone can understand, he thinks in a methodical way and has amassed success.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen